Seshu Tyagarajan is Chief Technology Officer of Candel Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Nov 23 | CADL Candel Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 0.9 | 17,328 | 15.60 k | 174,230 |
26 Nov 23 | CADL Candel Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 104,516 | 0.00 | 191,558 |
28 Apr 23 | CADL Candel Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.29 | 90,000 | 116.10 k | 90,000 |
9 Dec 22 | CADL Candel Therapeutics | Common Stock | Buy | Acquire P | No | No | 1.93 | 10,358 | 19.99 k | 13,358 |
8 Dec 22 | CADL Candel Therapeutics | Common Stock | Buy | Acquire P | No | No | 1.69 | 3,000 | 5.07 k | 3,000 |
28 Nov 22 | CADL Candel Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 73,684 | 0.00 | 73,684 |